2025-2034 Molecular Diagnostics For Sexually Transmitted Diseases Market Outlook: Key Drivers, Emerging Challenges, and Strategic Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Molecular Diagnostics For Sexually Transmitted Diseases Industry Market Size Be by 2025?
The market size for molecular diagnostics for sexually transmitted diseases has seen a rapid expansion in recent years. The market, which stood at $3.31 billion in 2024, is projected to increase to $3.67 billion in 2025, reflecting an impressive compound annual growth rate (CAGR) of 10.9%. A few factors behind this growth during the previous period include the rising incidence of sexually transmitted infections, the expanding utilization of nucleic acid amplification tests, amplified awareness due to government screening programs, assistance from international health organizations, and early usage in diagnostic laboratories.

What's the Long-Term Growth Forecast for the Molecular Diagnostics For Sexually Transmitted Diseases Market Size Through 2029?
There is an anticipated surge in the market size of molecular diagnostics for sexually transmitted diseases in the years to come, with an expected value of $5.48 billion by 2029. This significant growth, at a compound annual growth rate (CAGR) of 10.5%, is set to happen during the forecast period. The projected growth can be linked to various factors like the emphasis on early disease detection, an upsurge in bespoke diagnostic demand, the expansion of programs overseeing sexually transmitted infections, increased collaboration between public and private sectors, and a preference for non-invasive testing methodologies. The forthcoming period is expected to witness key trends like technological enhancement in molecular assay platforms, the invention of point-of-care diagnostic tools, the formulation of multiplex polymerase chain reaction (PCR)-based testing panels, progression in research and developing portable and automated systems, and incorporating artificial intelligence for interpreting results.

View the full report here:
https://www.thebusinessresearchcompany.com/report/molecular-diagnostics-for-sexually-transmitted-diseases-global-market-report

What Are the Key Growth Drivers Fueling the Molecular Diagnostics For Sexually Transmitted Diseases Market Expansion?
The molecular diagnostics market for sexually transmitted diseases is projected to expand due to the increasing incidence of these infections. These are diseases caused by bacteria, viruses, or parasites that are transmitted through sexual contact, primarily affecting the reproductive and urinary systems. The increasing incidence of sexually transmitted infections can be attributed mainly to the inconsistent use of protective measures, which enables easier transmission among sexually active individuals. Molecular diagnostics have a significant role in controlling these infections. They can detect pathogens early and accurately, even in people without symptoms, which enables prompt treatment, reduces disease transmission, and enhances overall patient health. In January 2024, the National Association of County and City Health Officials (NACCHO), a US-based nonprofit organization, reported a total of 3,755 cases of congenital syphilis, indicating a 31% increase between 2021 and 2022. Thus, due to the growing incidence of sexually transmitted infections, the molecular diagnostics market for sexually transmitted diseases is experiencing growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27351&type=smp

What Are the Key Trends Driving Molecular Diagnostics For Sexually Transmitted Diseases Market Growth?
Leading entities in the molecular diagnostics for sexually transmitted diseases market are currently concentrating on the creation of novel solutions like quick point-of-care polymerase chain reaction (PCR) devices as a way to enhance diagnostic speed, precision, and reach. These fast point-of-care PCR tools are mobile molecular diagnostics devices that consolidate sample preparation, amplification, and detection in one small unit, facilitating highly accurate pathogen identification beyond the confines of traditional lab environments. Take for instance, the Visby Medical Women's Sexual Health Test introduced in March 2025 by Visby Medical, a US-based firm specializing in diagnostics technology. This product is a one-use, handheld PCR device specially engineered to detect chlamydia, gonorrhea, and trichomoniasis from vaginal samples in just 30 minutes. This standalone device doesn't require any additional instrumentation or cold-chain logistics, comes with an integrated amplification system, and delivers lab-grade results directly at point-of-care to aid immediate clinical decision-making. It has been approved for prescription-based home use, distinguishing it as the first U.S. Food and Drug Administration (FDA) approved molecular diagnostic test for multiple sexually transmitted infections (STIs) that can be utilized beyond clinic environments. This product reveal indicates a trend towards decentralized diagnostic solutions that amplify reach, particularly in underprivileged or isolated communities.

How Is the Molecular Diagnostics For Sexually Transmitted Diseases Market Segmented?
The molecular diagnostics for sexually transmitted diseases market covered in this report is segmented

1) By Product: Instruments And Services, Consumables, Software
2) By Technology: Laboratory Testing, Point-Of-Care Testing
3) By Application: Chlamydia Trachomatis (CT) Or Neisseria Gonorrhoeae (NG) Testing, Syphilis Testing, Gonorrhea Testing, Herpes Simplex Virus (HSV) Testing, Human Papillomavirus (HPV) Testing, Human Immunodeficiency Virus (HIV) Testing, Trichomonas, Ureaplasma And Mycoplasma, Other Applications

Subsegment:
1) By Instruments And Services: Molecular Diagnostic Analyzers, Automated Polymerase Chain Reaction Systems, Nucleic Acid Extraction Instruments, Diagnostic Service Providers, Maintenance And Calibration Services, Installation And Training Services
2) By Consumables: Deoxyribonucleic Acid Extraction Kits, Ribonucleic Acid Extraction Kits, Polymerase Chain Reaction Reagents, Nucleic Acid Probes, Control And Reference Standards, Detection Enzymes And Buffers
3) By Software: Data Interpretation And Reporting Software, Polymerase Chain Reaction Workflow Management Software, Laboratory Information Management Systems, Diagnostic Decision Support Software, Quality Control Monitoring Software

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=27351&type=smp

Which Companies Are Leading the Charge in Molecular Diagnostics For Sexually Transmitted Diseases Market Innovation?
Major companies operating in the molecular diagnostics for sexually transmitted diseases market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Illumina Inc., Hologic Inc., bioMérieux S.A., QuidelOrtho Corporation, QIAGEN N.V., Cepheid, Sansure Biotech Inc., OraSure Technologies Inc., Meridian Bioscience, Seegene Inc., Visby Medical Inc., Zeesan Biotech, Binx Health Inc., GCC Biotech, GeneProof, and Solone Life Sciences India (P) Ltd.

Which Regions Are Leading the Global Molecular Diagnostics For Sexually Transmitted Diseases Market in Revenue?
North America was the largest region in the molecular diagnostics for sexually transmitted diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the molecular diagnostics for sexually transmitted diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=27351

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Speak With Our Expert:
Saumya Sahay,
Americas: +1 310-496-7795,
Asia: +44 7882 955267 & +91 8897263534,
Europe: +44 7882 955267,
Email: saumyas@tbrc.info

The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.